[(2S,3R,4S,5S,6R)-3,5-dihydroxy-2-[(2S,3R,4R,5R,6S)-4-hydroxy-2-methyl-5-[(2S)-2-methylbutanoyl]oxy-6-[[(1S,3R,4S,5S,6R,8R,10R,22S,23R,24R,26R)-4,5,23-trihydroxy-6,24-dimethyl-20-oxo-10-pentyl-2,7,9,21,25-pentaoxatricyclo[20.3.1.03,8]hexacosan-26-yl]oxy]oxan-3-yl]oxy-6-methyloxan-4-yl] (2R,3R)-3-hydroxy-2-methylbutanoate | 116446-43-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [(2S,3R,4S,5S,6R)-3,5-dihydroxy-2-[(2S,3R,4R,5R,6S)-4-hydroxy-2-methyl-5-[(2S)-2-methylbutanoyl]oxy-6-[[(1S,3R,4S,5S,6R,8R,10R,22S,23R,24R,26R)-4,5,23-trihydroxy-6,24-dimethyl-20-oxo-10-pentyl-2,7,9,21,25-pentaoxatricyclo[20.3.1.03,8]hexacosan-26-yl]oxy]oxan-3-yl]oxy-6-methyloxan-4-yl] (2R,3R)-3-hydroxy-2-methylbutanoate
• CAS: 116446-43-6
• 化学式: C₅₀H₈₆O₂₁
• 分子量: 1023.22
• InChiKey: MOJOPGARCXHPMT-QKUVMERUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  71
• 可旋转键数：
  16
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  294
• 氢给体数：
  7
• 氢受体数：
  21

反应信息

• 作为产物：
  描述：

  muricatin VII 生成 [(2S,3R,4S,5S,6R)-3,5-dihydroxy-2-[(2S,3R,4R,5R,6S)-4-hydroxy-2-methyl-5-[(2S)-2-methylbutanoyl]oxy-6-[[(1S,3R,4S,5S,6R,8R,10R,22S,23R,24R,26R)-4,5,23-trihydroxy-6,24-dimethyl-20-oxo-10-pentyl-2,7,9,21,25-pentaoxatricyclo[20.3.1.03,8]hexacosan-26-yl]oxy]oxan-3-yl]oxy-6-methyloxan-4-yl] (2R,3R)-3-hydroxy-2-methylbutanoate
  参考文献：
  名称：

  NODA, NAOKI;NISHI, MASATOSHI;MIYAHARA, KAZUMOTO;KAWASAKI, TOSHIO, CHEM. AND PHARM. BULL., 36,(1988) N 5, C. 1707-1713

  摘要：

  DOI：

文献信息

• Noda, Naoki; Nishi, Masatoshi; Miyahara, Kazumoto, Chemical and pharmaceutical bulletin, 1988, vol. 36, # 5, p. 1707 - 1713
  作者：Noda, Naoki、Nishi, Masatoshi、Miyahara, Kazumoto、Kawasaki, Toshio

  DOI：——

  日期：——
• NODA, NAOKI;NISHI, MASATOSHI;MIYAHARA, KAZUMOTO;KAWASAKI, TOSHIO, CHEM. AND PHARM. BULL., 36,(1988) N 5, C. 1707-1713
  作者：NODA, NAOKI、NISHI, MASATOSHI、MIYAHARA, KAZUMOTO、KAWASAKI, TOSHIO

  DOI：——

  日期：——